Cal-Maine Foods (CALM) Reports Record $4.3B Net Sales for Fiscal 2025
Cal-Maine Foods, Inc. (NASDAQ:CALM) is one of the best farmland and agriculture stocks to buy according to billionaires.
Insider Monkey Blog
KeyBanc Increases Corteva (CTVA) Price Target to $84, Reiterates “Overweight”
Corteva, Inc. (NYSE:CTVA) is one of the best farmland and agriculture stocks to buy according to billionaires.
CF Industries (CF) Launches CO2 Sequestration at Donaldsonville Complex
CF Industries Holdings, Inc. (NYSE:CF) is one of the best farmland and agriculture stocks to buy according to billionaires.
Deere (DE) Expands Digital Support with New DIY Service Platform
Deere & Company (NYSE:DE) is one of the best farmland and agriculture stocks to buy according to billionaires.
Biogen (BIIB) Price Target Hiked to $130 at UBS amid Leqembi Development
Biogen Inc. (NASDAQ:BIIB) is one of the top 10 medical AI companies to buy according to analysts.
Pediatrix Medical Group (MD) Appoints Kurt D. Newman to Board
Pediatrix Medical Group, Inc. (NYSE:MD) is one of the top 10 medical AI companies to buy according to analysts. On July 1, the company confirmed the appointment of Dr. Kurt D.
Tempus AI (TEM) Secures FDA Clearance for AI-Powered Heart Monitoring Software
Tempus AI, Inc. (NASDAQ:TEM) is one of the top 10 medical AI companies to buy according to analysts.
Eli Lilly (LLY) Partners with LTZ to Develop Myeloid Engager Therapies
Eli Lilly & Company (NYSE:LLY) is one of the top 10 medical AI companies to buy according to analysts.
Evolent Health (EVH) Bolsters Management Team
Evolent Health, Inc. (NYSE:EVH) is one of the top 10 medical AI companies to buy according to analysts.
Novo Nordisk (NVO) Turns the Page with New CEO Appointment
Novo Nordisk A/S (NYSE:NVO) is one of the top 10 medical AI companies to buy according to analysts.
Citi Affirms Buy Rating on Schrödinger (SDGR) amid Expanded Collaboration with Ajax Therapeutics
Schrödinger, Inc. (NASDAQ:SDGR) is one of the top 10 medical AI companies to buy according to analysts.
NeoGenomics (NEO) Targets Opportunity at $5 billion Liquid Biopsy Market
NeoGenomics, Inc. (NASDAQ:NEO) is one of the top 10 medical AI companies to buy according to analysts.
Simulations Plus (SLP) AI-Driven Drug Design Collaboration Yields Positive Results
Simulations Plus, Inc. (NASDAQ:SLP) is one of the top 10 medical AI companies to buy according to analysts.
Butterfly Network (BFLY) Delivers Record Q2 Revenue, Eyes Growth Through Innovation
Butterfly Network, Inc. (NYSE:BFLY) is one of the top 10 medical AI companies to buy, according to analysts.
Investing for Beginners: A College Student’s Guide to Getting Started
Investing often feels risky when tuition, rent, and late pizza drain thin wallets. Yet many undergraduates prove that small weekly deposits can grow into lasting wealth.
Top 10 Medical AI Companies to Buy According to Analysts
Artificial intelligence is transforming medical sciences in ways not seen before.
10 Best Rare Earth Stocks to Buy Now
Control of rare earth metals has emerged as a pawn in the broader conflict between China and the US.
The Role of Term Insurance in Long-Term Financial Planning
Financial planning is not a one-time task; it’s a continuous process that includes preparing for both expected and unexpected events.
Here’s Why Baron Global Advantage Fund’s Has Strong Conviction in NVIDIA (NVDA)
Baron Funds, an investment management company, released its “Baron Global Advantage Fund” investor letter for the second quarter of 2025.
Should You Consider Adding Loar Holdings (LOAR) to Your Portfolio?
Baron Funds, an investment management company, released its “Baron Global Advantage Fund” investor letter for the second quarter of 2025.
Does Illumina (ILMN) have an Attractive Risk-Reward Opportunity for Long-Term Investors?
Baron Funds, an investment management company, released its “Baron Global Advantage Fund” investor letter for the second quarter of 2025.
Does Taiwan Semiconductor Manufacturing Company Limited (TSM) have an Unmatched Competitive Position in Leading-Edge Semiconductor Manufacturing?
Baron Funds, an investment management company, released its “Baron Global Advantage Fund” investor letter for the second quarter of 2025.
What Makes Nu Holdings Ltd. (NU) an Investment Bet?
Baron Funds, an investment management company, released its “Baron Global Advantage Fund” investor letter for the second quarter of 2025.
Here’s What Supports Datadog’s (DDOG) Annual Share Gains
Baron Funds, an investment management company, released its “Baron Global Advantage Fund” investor letter for the second quarter of 2025.
B2PRIME Unveils Q2 2025 Growth as Founder Shares Key Milestones
B2PRIME Group, a global financial services provider for institutional and professional clients, has published its Founder’s Letter for Q2 2025, unveiling new strategic milestones...
Do You Believe in the Strong Fundamentals of Cloudflare (NET)?
Baron Funds, an investment management company, released its “Baron Global Advantage Fund” investor letter for the second quarter of 2025.
Here’s Why Baron Global Advantage Fund’s Estimate of MercadoLibre’s (MELI) Intrinsic Value Has Risen
Baron Funds, an investment management company, released its “Baron Global Advantage Fund” investor letter for the second quarter of 2025.
Endava plc (DAVA) Fell Due to Soft Demand Trends
Baron Funds, an investment management company, released its “Baron Global Advantage Fund” investor letter for the second quarter of 2025.
Does Globant S.A. (GLOB) Have a Long Runway for Growth?
Baron Funds, an investment management company, released its “Baron Global Advantage Fund” investor letter for the second quarter of 2025.
Sirius XM Holdings Inc. (NASDAQ:SIRI) Q2 2025 Earnings Call Transcript
Sirius XM Holdings Inc. (NASDAQ:SIRI) Q2 2025 Earnings Call Transcript July 31, 2025Sirius XM Holdings Inc. misses on earnings expectations.
Baron Global Advantage Fund’s Q2 2025 Investor Letter
Baron Funds, an investment management company, released its “Baron Global Advantage Fund” investor letter for the second quarter of 2025.
Enthusiasm Over Artificial Intelligence Boosted Nova Ltd. (NVMI) in Q2
Wasatch Global Investors, an asset management company, released its “Wasatch Small Cap Growth Strategy” second-quarter 2025 investor letter.
Here’s What Fueled Fabrinet’s (FN) Rise in Q2
Wasatch Global Investors, an asset management company, released its “Wasatch Small Cap Growth Strategy” second-quarter 2025 investor letter.
Do You Believe in the Growth Potential of Agilysys (AGYS)
Wasatch Global Investors, an asset management company, released its “Wasatch Small Cap Growth Strategy” second-quarter 2025 investor letter.
Goosehead Insurance (GSHD) Cooled Down in Q2 Following a Strong Run
Wasatch Global Investors, an asset management company, released its “Wasatch Small Cap Growth Strategy” second-quarter 2025 investor letter.
Wasatch Small Cap Growth Strategy Lowered Clearwater Analytics Holdings’ (CWAN) Weight
Wasatch Global Investors, an asset management company, released its “Wasatch Small Cap Growth Strategy” second-quarter 2025 investor letter.
Here’s What Caused BellRing Brands’ (BRBR) Sell-Off in Q2
Wasatch Global Investors, an asset management company, released its “Wasatch Small Cap Growth Strategy” second-quarter 2025 investor letter.
Wasatch Small Cap Growth Strategy’s Q2 2025 Investor Letter
Wasatch Global Investors, an asset management company, released its “Wasatch Small Cap Growth Strategy” second-quarter 2025 investor letter. U.S.
Here’s Why Starbucks (SBUX) Retreated in Q2
RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark Large Growth Fund” Q2 2025 investor letter.
PepsiCo (PEP) Slid on Concerns Over Slowing U.S. Consumption and Rising Competitive Pressure
RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark Large Growth Fund” Q2 2025 investor letter.
Increased Investor Confidence and Better Than Expected Results Boosted Microsoft (MSFT) in Q2
RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark Large Growth Fund” Q2 2025 investor letter.
Do You Believe in Apple’s (AAPL) Long-Term Compelling Value Proposition?
RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark Large Growth Fund” Q2 2025 investor letter.
RiverPark Large Growth Fund: Uber Technologies (UBER) was a Standout Performer During Q2
RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark Large Growth Fund” Q2 2025 investor letter.
Here’s Why UnitedHealth Group (UNH) Sold Off Sharply in Q2
RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark Large Growth Fund” Q2 2025 investor letter.
Favorable Market Response Lifted Meta Platforms (META)
RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark Large Growth Fund” Q2 2025 investor letter.
Morgan Stanley Upholds Overweight for Microsoft (MSFT), Lifts PT to $582
Microsoft Corporation (NASDAQ:MSFT) is one of the AI Stocks Making Waves on Wall Street. On July 31, Morgan Stanley analyst Keith Weiss raised the price target on the stock...
Nvidia (NVDA) Gets Vote of Confidence From Citi as AI Capex Set to Soar
NVIDIA Corporation (NASDAQ:NVDA) is one of the AI Stocks Making Waves on Wall Street. On July 31, Citi reiterated Nvidia and Broadcom as Buy and Advanced Micro Devices as Neutral...
Analysts Say Tesla’s (TSLA) Real Value May Lie in the Story, Not the Numbers
Tesla, Inc. (NASDAQ:TSLA) is one of the AI Stocks Making Waves on Wall Street. On July 31, Wolfe Research analyst Emmanuel Rosner reiterated a “Peerperform” rating on the...
Hedge Fund Resource Center
